New Key Statistics Module, Z-Score and F-Score
NAS:SGMO Key Ratios
| Market Cap $ M | 117.84 |
| Enterprise Value $ M | 94.25 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 2.04 |
| Price/Sales | 5.36 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 18.00 |
| EPS (TTM) $ | -1.86 |
| Beneish M-Score | -6.33 |
| 10-y EBITDA Growth Rate % | -6.40 |
| 5-y EBITDA Growth Rate % | 1.20 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.39 |
| EV-to-EBITDA | -0.42 |
| PEG | -- |
| Shares Outstanding M | 207.51 |
| Net Margin (%) | -1,749.06 |
| Operating Margin % | -1,294.38 |
| Pre-tax Margin (%) | -1,776.61 |
| Quick Ratio | 1.71 |
| Current Ratio | 1.71 |
| ROA % (ttm) | -128.18 |
| ROE % (ttm) | -194.40 |
| ROIC % (ttm) | -180.11 |
| Dividend Yield % | -- |
| Altman Z-Score | -22.94 |
SGMO Number of Guru Trades
SGMO Volume of Guru Trades
Gurus Latest Trades with NAS:SGMO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:SGMO is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Sangamo Therapeutics Inc Insider Transactions
No Available Data
News about NAS:SGMO
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers